DEXEDRINE SPANSULE
KNIGHT THERAPEUTICS INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DEXEDRINE SPANSULE in Canada?
A shortage of DEXEDRINE SPANSULE 10MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 1, 2026), but it has not started yet.
Why is DEXEDRINE SPANSULE not available?
The reason the manufacturer reported: Demand increase for the drug.
When will DEXEDRINE SPANSULE be available again?
The estimated resolution date (September 18, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
ADHD Medication Shortage in Canada: What to Know
Why ADHD medications go into shortage in Canada more often than most drug classes, which ones are most affected, and what to do if yours is short-supplied.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
APO-DEXTROAMPHETAMINE SR
Extended-ReleaseAPOTEX INC
TEVA-DEXTROAMPHETAMINE SR
Extended-ReleaseTEVA CANADA LIMITED
Other Products
DEXEDRINE SPANSULE
KNIGHT THERAPEUTICS INC.
DEXEDRINE
KNIGHT THERAPEUTICS INC.
DEXTROAMPHETAMINE
AA PHARMA INC
PMS-DEXTROAMPHETAMINE
PHARMASCIENCE INC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-09-18
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
01924559
Strength
10MG
Dosage Form
CAPSULE (SUSTAINED-RELEASE)
Route
ORAL
Active Ingredient
DEXTROAMPHETAMINE SULFATE
Tier
Unrated
Last Updated
2026-09-01
Reason for Shortage
Demand increase for the drug.
Other Products from KNIGHT THERAPEUTICS INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02468735
0.25MG · DIN 02381710
0.5MG · DIN 02381729
DIN 02332450
1G · DIN 02242980
DIN 02505223
400MG · DIN 02245828
30MG · DIN 02296152
DIN 02290308
25MG · DIN 01997602
20MG · DIN 01997572
5MG · DIN 01924516